KATHRYN STANSBURY: Open Payments
NPI 1841851862 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$881 in 30 payments from 14 companies in 2025. Trend: 2023 $509 · 2024 $647 · 2025 $881
Food & beverage: $881
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $269 |
| Merck Sharp & Dohme LLC | 8 | $202 |
| SCPHARMACEUTICALS INC. | 4 | $64 |
| Novartis Pharmaceuticals Corporation | 3 | $58 |
| Inspire Medical Systems, Inc. | 1 | $51 |
| ABIOMED | 1 | $41 |
| Novo Nordisk Inc | 2 | $40 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Stryker Corporation | 1 | $23 |
| Philips North America LLC | 1 | $23 |
Products named: AVEIR, VERQUVO, FUROSCIX, LEQVIO, INSPIRE, Wegovy, Kerendia, MERLIN@HOME.
Industry payments across LA — which companies pay providers there.
